Abstracts Archive - Page 2297 of 2605 - ACR Meeting Abstracts

Abstract Number: 2016 • 2013 ACR/ARHP Annual Meeting
Inflamamatory Myositis-Increased Incidence In Fire Department Of New York Firefighters After World Trade Center Exposure
Basit Qayyum¹, Michelle S Glaser^2,3, Nadia Jaber³, Rachel Zeig-Owens^2,3, Mayris P Webber^3,4, Anna Nolan^3,5, Kerry J Kelly³ and David J Prezant^3,6, ¹New York University School of Medicine, New York, NY, ²Medicine, Montefiore Medical Center, Bronx, NY, ³Bureau of Health Services Fire Department of New York, Brooklyn, NY, ⁴Medicine and Epideiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY, ⁵Medicine, New York University School of Medicine, New York, NY, ⁶Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Inflammatory myositis (IM) is extremely rare in white middle-aged males. Incidence rates in males ranging from 0.25 to 5 per million. We describe a…
Abstract Number: 2017 • 2013 ACR/ARHP Annual Meeting
Hyper Ferritinemia Suggests a High Frequency Of Macrophage Activation Syndrome In a Large Adult Severe Sepsis Cohort: A Role For Anakinra?
Bita Shakoory¹, Joseph A. Carcillo² and Steven Opal³, ¹Medicine/Rheumatology, Temple University, Philadelphia, PA, ²Pediatrics, University of Pittsburg Medical Center, Pittsburgh, PA, ³Medicine, Brown University, Providence, RI
Background/Purpose: Inreased ferritin levels are protective during infection whereas but very very high level are associated with MAS in rheumatologic disease cTo determine frequency of…
Abstract Number: 2018 • 2013 ACR/ARHP Annual Meeting
Hemophagocytic Lymphohistiocytosis As a Clinical Syndrome Of Autoimmune Diseases, Haematology, Oncology and Infectious Diseases
César Antonio Egües Dubuc, Vicente Aldasoro Cáceres, Miren Uriarte Ecenarro, Carlos Meneses Villalba, Nerea Errazquin Aguirre, Iñaki Hernando Rubio, Olga Maiz Alonso, Jorge Cancio Fanlo, Esther Uriarte Isacelaya and Joaquin Belzunegui Otano, Rheumatology, Donostia University Hospital, San Sebastián, Spain
Background/Purpose :Hemophagocytic Lymphohistiocytosis (HLH) is a severe and acute inflammatory syndrome usually fatal without treatment. HLH includes a spectrum of diseases produced by the proliferation and activation of…
Abstract Number: 2019 • 2013 ACR/ARHP Annual Meeting
Kikuchi-Fujimoto disease : Features and Outcome Of 91 Patients In France
Guillaume Dumas¹, Virginie Prendki², Julien Haroche³, Patrice Cacoub⁴, Zahir Amoura³, Lionel Galicier⁵, Olivier Meyer⁶, Christophe Rapp⁷, Christophe Deligny⁸, Bertrand Godeau⁹, Elisabeth Aslangul¹⁰, Olivier Lambotte¹¹, Thomas Papo¹², Jacques Pouchot¹³, Mohamed Hamidou¹⁴, Gilles Grateau¹⁵, Eric Hachulla¹⁶, Thierry Carmoi¹⁷, Robin Dhote¹⁸, Magdalena Gerin¹⁹, Arsene Mekinian²⁰, Fréderique Charlotte²¹, Dominique Farge⁵, Thierry Molina²² and Olivier Fain²³, ¹internal medicine, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France, ²internal medicine, Geriatry, Hôpitaux Universitaires de Genève, Genève, Switzerland, ³Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, ⁴Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, ⁵Internal Medicine, Hopital St Louis, AP-HP, Paris, France, ⁶Rheumatology, Bichat University Hospital, Paris, France, ⁷intenal medicine, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France, ⁸Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique, ⁹Internal Medicine, University of Paris, AP-HP, Hôpital Mondor Créteil, Creteil, France, ¹⁰internal medicine, hôpital Hotel Dieu, AP-HP, Paris, France, ¹¹Internal Medicine, Hopital Kremlin Bicêtre, Kremlin Bicêtre, France, ¹²Internal Medicine, Bichat Hospital, Paris, Paris, France, ¹³internal medicine, Hôpital Européen Georges Pompidou, AP-HP, Paris, France, ¹⁴CHU Hôtel Dieu, Nantes, Nantes, France, ¹⁵Service De Médecine Interne, Hopital Tenon, Paris, France, ¹⁶Internal Medicine, University Hospital Lilles, Lille CEDEX, France, ¹⁷internal medicine, Hôpital d'Instrcution des Armées du Val de Grace, Paris, France, ¹⁸Internal Medicine, Avicenne University Hospital, Bobigny, France, ¹⁹Internal Medicine, Hôpital Jean Verdier, AP-HP, Bondy, France, ²⁰internal medicine, Hôpital Jean Verdier, AP-HP, Bondy, FL, France, ²¹Department of Anatomic Pathology, Hopital Pitié-Salpétrière, Paris, France, ²²Department of Anatomic Pathology, hôpital Hotel Dieu, AP-HP, Paris, France, ²³Hôpital Saint Antoine, DHU i2B, Service de Médecine Interne, paris, France
Background/Purpose: Kikuchi Fujimoto disease (KFD) constitutes a rare cause of cervical lymphadenitis, usually reported in Asia. Data about this disease are scarce in Europe. The…
Abstract Number: 2020 • 2013 ACR/ARHP Annual Meeting
Clinical Characteristics In Japanese Patients With IgG4-Related Disease
Kazu Hamada, Yoshinori Taniguchi, Yoshiko Shimamura, Koji Ogata, Kosuke Inoue, Taro Horino, Yoshitaka Kumon, Kahori Hirose, Masamitsu Hyodo and Yoshio Terada, MD, Nankoku, Japan
Background/Purpose: IgG4-related disease (IgG4-RD) is the new entity, which is a multisystem and fibroinflammatory condition. It is characterized by progressive scarring and dysfunction of affected…
Abstract Number: 2021 • 2013 ACR/ARHP Annual Meeting
The Proportion Of IgG4-Related Aortitis In Patients Diagnosed As Chronic Inflammation Of Aorta In Pathology
Bon San Koo¹, Bin Yoo¹, Chang-Keun Lee¹, You Jae Kim¹, Seokchan Hong², Yong-Gil Kim¹, Wook Jang Seo³ and Kyung joo Ahn⁴, ¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ²Department of rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ³Seoul Veterans Hospital, Seoul, South Korea, ⁴KEPCO medical center, Seoul, South Korea
Background/Purpose: The purpose of our study was to identify the proportion of IgG4-related aortitis in patients diagnosed with chronic inflammation of aorta in pathology and…
Abstract Number: 2022 • 2013 ACR/ARHP Annual Meeting
The Comparison Between IgG4-Related Retroperitoneal Fibrosis and Idiopathic Retroperitoneal Fibrosis
Bon San Koo¹, Bin Yoo¹, Chang-Keun Lee¹, Yong-Gil Kim¹, You Jae Kim¹, Seokchan Hong², Wook Jang Seo³ and Kyung joo Ahn⁴, ¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ²Department of rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ³Seoul Veterans Hospital, Seoul, South Korea, ⁴KEPCO medical center, Seoul, South Korea
The comparison between IgG4-related retroperitoneal fibrosis and idiopathic retroperitoneal fibrosis Background/Purpose: The purpose of our study was to identify the ratio of IgG4-related retroperitoneal fibrosis…
Abstract Number: 2023 • 2013 ACR/ARHP Annual Meeting
IgG4-Related Midline Destructive Lesion: Expanding The Spectrum Of Organ Involvement In IgG4-Related Disease
Emanuel Della Torre¹, Donald Krause², Vikram Deshpande³, Vinay Mahajan⁴, Hamid Mattoo⁵, Shiv Pillai⁶ and John Stone⁷, ¹Cancer Center, Massachusetts General Hospital, Boston, MA, ²Medicine, St. Joseph's Hospital, Bangor, ME, ³Pathology, Massachusetts General Hospital, Boston, MA, ⁴Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁶Oncology, Massachusetts General Hospital, Boston, MA, ⁷Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Midline destructive lesion (MDL) is a fibroinflammatory condition involving the nose, paranasal sinuses, and palate with relentless erosion through contiguous facial structures. A variety…
Abstract Number: 2024 • 2013 ACR/ARHP Annual Meeting
Elevated IgG4+ Plasmablasts In Patients With Active, Untreated IgG4-Related Disease
Zachary S. Wallace¹, Vinay Mahajan², Mollie Carruthers³, Hamid Mattoo⁴, Shiv Pillai⁵ and John H. Stone³, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ²Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Rheumatology, Massachusetts General Hospital, Boston, MA, ⁴Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Oncology, Massachusetts General Hospital, Boston, MA
Background/Purpose: IgG4-delated disease (IgG4-RD) is an immune-mediate condition responsible for inflammatory lesions that can affect nearly every organ. Diagnosis is challenging as it relies upon…
Abstract Number: 2025 • 2013 ACR/ARHP Annual Meeting
Distinctive Expression Profiles Of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Contains Helpful Suggestions For Understanding and Discriminating These Diseases
Yoshinobu Koyama¹, Motohiko Tanino², Hirokazu Shiraishi³, Shuji Nagano⁴, Toshiyuki Ota⁴ and Toshie Higuchi⁵, ¹Division of Rheumatology, Okayama Red Cross General Hospital, Okayama, Japan, ²DNA Chip Research Inc., Yokohama, Japan, ³Orthopedics, Iizuka Hospital, Iizuka, Japan, ⁴Center for Rheumatic Diseases, Iizuka Hospital, Iizuka, Japan, ⁵Center for Autoimmune Diseases, Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan
Background/Purpose: There are many clinical similarities between polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA). It has been reported that the specificity for discriminating PMR from…
Abstract Number: 2026 • 2013 ACR/ARHP Annual Meeting
Initial Dose Of Prednisolone For Japanese Patients With Polymyalgia Rheumatica
Akiko Aoki¹, Hiroshi Oka² and Mitsuyuki Nakamura³, ¹General Medicien, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan, ²Rheumatic Disease Center, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan, ³Rheumatology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
Background/Purpose: Polymyalgia rheumatica (PMR) is a common inflammatory condition of elderly persons. Clinical symptoms respond to low-dose glucocorticoids, but treatment is often required for several…
Abstract Number: 2027 • 2013 ACR/ARHP Annual Meeting
Treatment Of Refractory Adult-Onset Still’s Disease With Abatacept : Report Of Five Cases
Hye Jin Oh¹, Myung Jae Yun², Kyong Rok Kim², Sang Hyun Joo², Jae Myung Lee², Jin Kyun Park², Eun Bong Lee², Yeong Wook Song³ and Eun Young Lee², ¹Internal Medicine, Rheumatology, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, ³Internal Medicine,Rheumatology, Seoul National University Hospital, Seoul, South Korea
Background/Purpose: Adult onset Still’s disease (AOSD) is a rare disorder of unknown etiology and systemic inflammatory disorder characterized by spiking fever, arthritis, evanescent rash and…
Abstract Number: 2028 • 2013 ACR/ARHP Annual Meeting
Efficacy and Safety Of Biologic Agents In Adult-Onset Still’s Disease: A Long-Term Follow-Up Of 19 Patients At a Single Referral Center
Giulio Cavalli^1,2, Stefano Franchini¹, Alvise Berti¹, Corrado Campochiaro¹, Barbara Guglielmi¹, Maria Grazia Sabbadini¹, Elena Baldissera³ and Lorenzo Dagna^4,5, ¹Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy, ²San Raffaele Scientific Institute, Milan, Italy, ³Vita-Salute San Raffaele University, Milano, Italy, ⁴Vita-Salute San Raffaele University, Milan, Italy, ⁵Medicine and Clinical Immunology, San Raffaele Scientific Institute, Milan, Italy
Background/Purpose: No data comparing the long-term outcome of Adult-Onset Still’s Disease (AOSD) patients treated with different biological drugs is currently available. We evaluated the efficacy…
Abstract Number: 1991 • 2013 ACR/ARHP Annual Meeting
Gout In Ambulatory Care Settings In The US: 1993-2009
Eswar Krishnan and Linjun Chen, Medicine, Stanford University, Palo Alto, CA
Background/Purpose: Gouty arthritis (gout) is primarily cared for in ambulatory care settings. Yet, there are few nationally representative data on ambulatory health care utilization of…
Abstract Number: 1992 • 2013 ACR/ARHP Annual Meeting
Trends In Outpatient Treatment Of Gout In The US: From 1993 To 2009
Eswar Krishnan and Linjun Chen, Medicine, Stanford University, Palo Alto, CA
Background/Purpose: Gouty arthritis (gout) is primarily managed in the community by primary care providers. Relatively little is known about the treatment patterns as well as…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].